ArticleJournal of experimental & clinical cancer research : CR2017

Intracellular pH-responsive and rituximab-conjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells.

Shoubing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.